Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

LiYan Dong

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Cancer Medicine|March 3, 2023
Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 studyAlexander Lesokhin, Richard LeBlanc, Meletios A Dimopoulos, et al.
Leukemia|June 14, 2023
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantationEnrique M Ocio, Aurore Perrot, Pierre Bories, et al.
Life Sciences|March 31, 2015
Evaluation of serum midkine as a biomarker in differentiated thyroid cancerZhaowei Meng, Jian Tan, Guizhi Zhang, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Cancer Medicine|March 3, 2023
Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 studyAlexander Lesokhin, Richard LeBlanc, Meletios A Dimopoulos, et al.
Leukemia|June 14, 2023
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantationEnrique M Ocio, Aurore Perrot, Pierre Bories, et al.
Life Sciences|March 31, 2015
Evaluation of serum midkine as a biomarker in differentiated thyroid cancerZhaowei Meng, Jian Tan, Guizhi Zhang, et al.
Pageof 6